Table I.

Identification of natural CXCL8 by Edman degradation and mass spectrometry

CXCL8 isoform
NH2-terminal sequencea
Percentage of total amount of CXCL8b
 −2         10      
CXCL8(-2–77) 7.8 
CXCL8(-2–77)Cit5 0.7 
CXCL8(1–77)   25.9 
CXCL8(1–77)Cit5   4.1 
CXCL8(2–77)    5.5 
CXCL8(2–77)Cit5    0.7 
CXCL8(3–77)     1.1 
CXCL8(6–77)        44.1 
CXCL8(8–77)          9.0 
CXCL8(9–77)           1.2 
CXCL8 isoform
NH2-terminal sequencea
Percentage of total amount of CXCL8b
 −2         10      
CXCL8(-2–77) 7.8 
CXCL8(-2–77)Cit5 0.7 
CXCL8(1–77)   25.9 
CXCL8(1–77)Cit5   4.1 
CXCL8(2–77)    5.5 
CXCL8(2–77)Cit5    0.7 
CXCL8(3–77)     1.1 
CXCL8(6–77)        44.1 
CXCL8(8–77)          9.0 
CXCL8(9–77)           1.2 
a

X stands for an unidentified residue (on Cys positions) and B stands for citrulline. Numbering corresponds to the position of the amino acids in CXCL8(1-77).

b

The relative amount of the different CXCL8 isoforms was obtained from the yields for the different amino acids during Edman degradation on >20 RP-HPLC fractions from a large batch of leukocytes from pooled blood donations (Table S1).

or Create an Account

Close Modal
Close Modal